Page 9 - Current Reports News Today

May 2024 Investor Presentation Fiscal 2024 Second Quarter and Year-to-Date Financial Results ...

Reports First Quarter Fiscal Year 2024 Financial Results ...

Application based on results from the CheckMate -8HW study, in which Opdivo plus Yervoy demonstrated statistically significant and clinically meaningful improvement in progression-free survival...

Investor Update as of May 6, 2024 The second quarter and full year 2024 estimates provided below are based on the current estimates of Spirit Airlines, Inc. and...

Strategic and tactical changes benefiting unit revenue  Expect cost saving initiatives to benefit 2024 by over $75 million; annualized run-rate savings estimated at over $100 million DANIA BEACH,...

Forward-looking statements Some of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the...

Application based on results from CheckMate -67T, the first Phase 3 trial of the subcutaneous formulation of nivolumab to evaluate and demonstrate noninferior pharmacokinetics, efficacy and...

Bluebird bio, Inc. announced today that it has completed the first commercial cell collection for LYFGENIA , a one-time gene therapy for the treatment of sickle cell disease in patients with a...

Atlas Energy Solutions Inc. today reported financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Highlights Total sales of $192.7 million Net income of...

- Occupancy Increased 320 Basis Points At Quarter End Compared To 2023 - ...